These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36743658)

  • 1. COVID-19-related liver injury: Focus on genetic and drug-induced perspectives.
    Parchwani D; Sonagra AD; Dholariya S; Motiani A; Singh R
    World J Virol; 2023 Jan; 12(1):53-67. PubMed ID: 36743658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between COVID-19 and hepatitis B: A systematic review.
    He YF; Jiang ZG; Wu N; Bian N; Ren JL
    World J Gastroenterol; 2022 Dec; 28(46):6599-6618. PubMed ID: 36569273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection.
    Parchwani D; Dholariya S; Katoch C; Singh R
    World J Methodol; 2022 Sep; 12(5):438-447. PubMed ID: 36186744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19.
    Higuera-de la Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Chapa-Azuela O; Chávez-Morales A; Rosales-Salyano VH
    Liver Res; 2021 Mar; 5(1):21-27. PubMed ID: 33520337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.
    Codoni G; Kirchner T; Engel B; Villamil AM; Efe C; Stättermayer AF; Weltzsch JP; Sebode M; Bernsmeier C; Lleo A; Gevers TJ; Kupčinskas L; Castiella A; Pinazo J; De Martin E; Bobis I; Sandahl TD; Pedica F; Invernizzi F; Del Poggio P; Bruns T; Kolev M; Semmo N; Bessone F; Giguet B; Poggi G; Ueno M; Jang H; Elpek GÖ; Soylu NK; Cerny A; Wedemeyer H; Vergani D; Mieli-Vergani G; Lucena MI; Andrade RJ; Zen Y; Taubert R; Terziroli Beretta-Piccoli B
    JHEP Rep; 2023 Jan; 5(1):100605. PubMed ID: 36440259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review of SARS-CoV-2-Associated Hepatic Dysfunction and the Impact on the Clinical Outcome of COVID-19.
    Radivojevic A; Abu Jad AA; Ravanavena A; Ravindra C; Igweonu-Nwakile EO; Ali S; Paul S; Yakkali S; Teresa Selvin S; Thomas S; Bikeyeva V; Abdullah A; Balani P
    Cureus; 2022 Jul; 14(7):e26852. PubMed ID: 35974857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of SARS-CoV-2 Invasion into the Liver and Hepatic Injury in Patients with COVID-19.
    Zhang X; Yu Y; Zhang C; Wang H; Zhao L; Wang H; Su Y; Yang M
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022003. PubMed ID: 35070210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute-on-chronic liver failure in patients with severe acute respiratory syndrome coronavirus 2 infection.
    Liptak P; Nosakova L; Rosolanka R; Skladany L; Banovcin P
    World J Hepatol; 2023 Jan; 15(1):41-51. PubMed ID: 36744167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
    Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V
    Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.